Abstract:Objective To evaluate the impact of rosiglitazone (Ros) on liver expression of peroxisome proliferator-activated receptor γ (PPARγ),nuclear factor (NF-κB) and cyclooxygenase-2(COX-2) in treatment of nonalcoholic steatohepatitis (NASH) rats.Methods Thirty Sprague-Dawley rats were divided into normal group,model group and Ros treated group with 10 each.Except the normal group,the other two groups were given high fat diet for 12 weeks for NASH model.The rats in Ros treated group were gavaged 4 mg/kg of Ros daily at the 12th week for 8 weeks.All rats were sacrificed at the 20th week for blood sample and liver tissue.Biochemical parameters of liver function,lipid metabolism,glycometabolism and antioxidant enzyme activities were measured.The histological change of the liver were assessed with HE and Masson staining.The level of tumor necrosis factor (TNF)-α and prostaglandin E2 (PGE2) was measured using ELISA.The expression of PPARγ,NF-κB and COX-2 was detected with immunohistochemistry.The mRNA and protein expressions of COX-2 were tested by real-time PCR and Western blotting,respectively.Results In comparison with model group,Ros treated group showed significant improvement in hepatic steatosis,inflammation and fibrosis(all P value<0.05).In model group,the serum levels of fasting blood glucose,insulin and HOMA-insulin resistance index (HOMA-IRI),total cholesterol (TC),total triglyeride (TG),lowdensity lipoprotein cholesterol (LDL-C) and free fatty acids were increased,but HDL-C level was decreased.All above parameters markedly improved after Ros treatment.The levels of ALT and AST,total anti-oxidation competence,superoxide dismutase,catalase,glutathione peroxidase and malondialdehyde in Ros treated group were significantly ameliorated when compared with those in model group.Immunohistochemistry showed that the expression of NF-κB and COX-2 was significantly elevated,but PPARγ was decreased in model group.Real-time PCR and Western blot revealed that the mRNA and protein expressions of COX-2 were higher in the model group than those in normal group (0.57±0.08 vs 0.38±0.03;2.83±0.24 vs 1.00±0.03,P=0.000 and P=0.004,respectively),but significantly lower in Ros treated group (0.55±0.06 and 1.84±0.13,P<0.01).Conclusions Ros can reduce oxidative stress and insulin resistance in NASH rats by activing PPARγ expression and inhibiting expression of NF-κB and cyclooxygenases.

Experimental Study of Osthole on Inhibiting Atherosclerotic Formation in Rats

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Therapeutic Effect of Osthole on Renovascular Hypertension-Induced Cardiac Hypertrophy in Rats

Therapeutic Effect of Osthole on Hyperlipidemic Fatty Liver in Rats

Experimental Study of Osthole on Treatment of Hyperlipidemic and Alcoholic Fatty Liver in Animals.

Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.

Involvement of Hepatic Peroxisome Proliferator-Activated Receptor Α/γ in the Therapeutic Effect of Osthole on High-Fat and High-Sucrose-induced Steatohepatitis in Rats.

Study of the Effects of Osthole on Blood Estradioland Lipase in Animals and Their Relationship

Comparison of the Effects of Different Osthole Preparations on Blood Lipid and Hepatic Lipid in Hyperlipidemic Mice

Anti-atherosclerosis of Oligomeric Proanthocyanidins from Rhodiola Rosea on Rat Model Via Hypolipemic, Antioxidant, Anti-Inflammatory Activities Together with Regulation of Endothelial Function

Osthole Improves Fat Milk-Induced Fatty Liver in Rats: Modulation of Hepatic PPAR-alpha/gamma-mediated Lipogenic Gene Expression.

Therapeutic Effect of Osthole on Alcohol-Indced Fatty Liver in Mice

Osthole Improves Alcohol‐induced Fatty Liver in Mice by Reduction of Hepatic Oxidative Stress

The Effect of Rosiglitazone in Modulating Cyclooxygenases-2 in Nonalcoholic Steatohepatitis Rats

Effect of Atorvastatin on the Expression of Heme Oxygenase-1 in Atherosclerotic Rats

Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats

Protective effects of Osthole on renal ischemia reperfusion injury

Effects of Osthole on Protein Expression of CYP7A1, DGAT2 and PPARalpha/gamma in Fat Milk-Induced Fatty Liver Rats

Effects of osthole on antithrombosis and its mechanisms

PPARα/γ Antagonists Reverse the Ameliorative Effects of Osthole on Hepatic Lipid Metabolism and Inflammatory Response in Steatohepatitic Rats

Osthole Inhibits Oleic Acid/lipopolysaccharide-Induced Lipid Accumulation and Inflammatory Response Through Activating PPARα Signaling Pathway in Cultured Hepatocytes.